Biomagentics Diagnostics finalizes agreement for fiber optic biosensor

Biomagnetics Diagnostics, Corp., has announced the finalization of a "Patent License Agreement" with Los Alamos National Security.

As part of the agreement, Biomagnetics will be given access to the Triggered Optical Biosensor and Integrated Optical Biosensor System technology, which has been developed at the Los Alamos National Laboratory.

The Integrated Optical Biosenor System is a relatively new classification of pathogen detection equipment that utilizes advanced fiber optic-based technology to aid in detecting a wide variety of human and animal pathogens.

The devices are designed specifically to be field deployable as well as ultra-portable to allow for the rapid detection of various viral and bacterial pathogens by relatively untrained personnel outside of the laboratory setting.

"We are very excited to have completed this agreement with Los Alamos National Security, which gives us access to some of the most technologically advanced and exciting biosensor technology in existence," Biomagnetics said in a statement. "The Integrated Optical Biosensor we plan to introduce into the marketplace, the technology developed at Los Alamos National Laboratory, is truly revolutionary.

"Additionally, the platform was specifically designed to be operated by personnel with only minimal training. These features make IBOS the perfect platform for field and point of care testing for the diagnosis of HIV/AIDS, hepatitis, malaria, cholera and potentially dozens of other diseases that kill millions of people each year. We look forward to working with the lab personnel on this and other endeavors."

As part of the agreement, Biomagnetics will be given access to the Triggered Optical Biosensor and Integrated Optical Biosensor System technology, which has been developed at the Los Alamos National Laboratory.

The Integrated Optical Biosenor System is a relatively new classification of pathogen detection equipment that utilizes advanced fiber optic-based technology to aid in detecting a wide variety of human and animal pathogens.

The devices are designed specifically to be field deployable as well as ultra-portable to allow for the rapid detection of various viral and bacterial pathogens by relatively untrained personnel outside of the laboratory setting.

"We are very excited to have completed this agreement with Los Alamos National Security, which gives us access to some of the most technologically advanced and exciting biosensor technology in existence," Biomagnetics said in a statement. "The Integrated Optical Biosensor we plan to introduce into the marketplace, the technology developed at Los Alamos National Laboratory, is truly revolutionary.

"Additionally, the platform was specifically designed to be operated by personnel with only minimal training. These features make IBOS the perfect platform for field and point of care testing for the diagnosis of HIV/AIDS, hepatitis, malaria, cholera and potentially dozens of other diseases that kill millions of people each year. We look forward to working with the lab personnel on this and other endeavors."